| Symbol | AIMN |
|---|---|
| Name | AIMWELL PARTNERS INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 36602 United States AL 11 n water st |
| Telephone | +1 678-999-6242 |
| Fax | — |
| — | |
| Website | http://aimwellbio.com |
| Incorporation | US |
| Incorporated On | 2022 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | Alternative Reporting Standard |
| CIK | 0000058411 |
| Description | Aimwell Partners Inc. (OTC: AIMN) is a holding company focused on healthcare intelligence, regulatory technology, and AI-driven verification infrastructure. Through its wholly owned brand and operating platform, AimwellBio, the company develops source-verified intelligence systems for the biopharmaceutical and healthcare industries, including regulatory monitoring, clinical intelligence, hallucination containment, and the Federated Health Intelligence Network (FHIN). Aimwell Partners’ mission is to provide decision-ready intelligence infrastructure designed to improve trust, verification, and institutional memory across healthcare and life sciences organizations. Additional info from OTC: |
No news found.